Braden scale risk stratification, repositioning schedules, support surface selection, and microclimate management to prevent hospital-acquired pressure injury
Developed by Barbara Braden and Nancy Bergstrom in 1987, the Braden Scale remains the most widely validated and used pressure injury risk-assessment instrument in acute and long-term care. It scores six subscales to produce a total risk score guiding preventive intervention intensity.
The Braden Scale evaluates: (1) Sensory perception — ability to respond meaningfully to pressure-related discomfort; (2) Moisture — degree of skin exposure to moisture from incontinence, perspiration, or wound drainage; (3) Activity — degree of physical activity; (4) Mobility — ability to change and control body position; (5) Nutrition — usual food intake pattern; (6) Friction and shear — the only subscale scored 1–3 rather than 1–4, assessing assistance required for movement and the degree of sliding against sheets/surfaces.
Total scores stratify risk: ≤9 severe risk, 10–12 high risk, 13–14 moderate risk, 15–18 mild risk, ≥19 no measurable risk (in some adaptations, ≤18 is the general "at risk" cutoff for adult acute care). Risk category should never be used in isolation — clinical judgment, additional risk factors (advanced age, prior pressure injury, vascular disease, device-related pressure, ICU admission, vasopressor use, prolonged surgery) and the pace of condition change must modify the prevention plan.
The scale has been validated across thousands of patients with sensitivity generally reported in the 83–100% range and specificity 64–90% depending on setting and cutoff, though performance is notably lower in some populations (e.g., critical care), which is why the 2019 NPIAP/EPUAP/PPPIA International Guideline recommends structured risk assessment be combined with skin assessment and clinical judgment rather than the scale alone.
Repositioning interrupts sustained tissue loading, allowing capillary reperfusion before ischemic injury accumulates. The traditional q2h interval originates from mid-20th-century capillary closing pressure estimates, but contemporary evidence shows the optimal interval depends heavily on support surface specification and individual tissue tolerance.
The historical q2h repositioning standard traces to Eugene Landis's 1930 capillary pressure measurements (~32 mmHg mean, with a range now recognized as highly variable between individuals and tissue types), extrapolated to the assumption that any surface exceeding capillary pressure for more than roughly two hours risks ischemic injury. Modern tissue tolerance testing has shown this is an oversimplification: interface pressure alone does not equal injury risk, and duration, shear, microclimate, and individual tissue tolerance interact.
The pragmatic multi-site TURN (Turning for Ulcer ReductioN) trial (2018, Bergstrom et al.) randomized nursing-home residents on high-density foam mattresses to q2h, q3h, or q4h repositioning and found no significant difference in pressure injury incidence between groups — suggesting that on a good reactive support surface, less frequent repositioning may be adequate for many residents, though the trial's findings should be applied cautiously and individualized, particularly for higher-risk patients.
Current NPIAP/EPUAP/PPPIA guidance recommends an individualized repositioning schedule based on the support surface in use, the patient's skin/tissue tolerance (assessed by timing skin response after repositioning — non-blanchable erythema persisting after position change signals the interval is too long), overall clinical status, and treatment goals — rather than a rigid universal interval.
30-degree lateral tilt technique: rather than the traditional 90-degree side-lying position (which loads the trochanter directly and produces very high localized interface pressure), the 30-degree tilt uses pillows/wedges to angle the patient partially onto their side, distributing weight across the buttock and lateral thigh rather than concentrating it on the greater trochanter, substantially reducing peak interface pressure at that bony prominence.
Repositioning interval should be individualized to the support surface and reassessed by direct skin inspection at each turn — if non-blanchable erythema is present when the patient is repositioned, the interval must be shortened regardless of what protocol or guideline default is in use.
The 2019 NPIAP/EPUAP/PPPIA International Clinical Practice Guideline provides an evidence-based algorithm for selecting support surfaces based on pressure injury risk category, existing injury, and patient-specific factors such as moisture exposure and need for microclimate control.
Reactive support surfaces (high-specification foam, viscoelastic/memory foam, gel): provide constant, evenly distributed low pressure by conforming to body contours, increasing the surface area over which weight is borne. Appropriate first-line for patients at mild-to-moderate risk without existing pressure injury. No moving parts, lower cost, no power requirement.
Alternating pressure air mattresses/overlays: cyclically inflate and deflate air cells (typically on a several-minute cycle) so that different body areas are sequentially loaded and unloaded, providing intermittent relief of pressure without manual repositioning. Indicated for moderate-to-high risk patients or those with an existing Stage 1–2 injury who cannot tolerate frequent manual repositioning.
Low-air-loss surfaces: air-permeable surfaces that provide continuous low-pressure support while allowing airflow across the skin surface, actively managing microclimate (temperature and moisture) at the interface — particularly valuable for patients with heavy perspiration, incontinence, or multiple/deep pressure injuries requiring both pressure redistribution and moisture control.
Powered air-fluidized (high air loss) surfaces: beads fluidized by warm airflow create a surface with extremely low, evenly distributed interface pressure and excellent microclimate control; reserved for the most severe cases — multiple Stage 3–4 injuries, myocutaneous flap/graft postoperative care — due to high cost and equipment weight/logistics.
Selection should also weigh: patient weight/bariatric needs (surface weight capacity), need for CPR-capable rapid deflation, infection control requirements, moisture management needs, and whether the patient can be nursed off the affected area entirely on an alternative surface (e.g., specialty chair cushion) during out-of-bed periods, since pressure injury prevention must extend beyond the bed to seating surfaces.
Elevated skin temperature and excess moisture at the skin-support-surface interface independently increase pressure injury risk by softening tissue and increasing metabolic demand in already-compromised, hypoperfused skin. Microclimate management is now recognized as a distinct pillar of prevention alongside pressure redistribution.
Skin subjected to sustained pressure is already ischemic and metabolically vulnerable; superimposed heat raises local tissue metabolic rate (via the Q10 effect, roughly a 10% increase in metabolic demand per 1°C rise), worsening the oxygen supply-demand mismatch. Moisture independently reduces the coefficient of friction changes and the mechanical integrity of the stratum corneum, increasing susceptibility to shear injury and lowering the pressure threshold required to cause tissue damage. Low-air-loss and powered surfaces address this directly by circulating air across the skin interface to wick moisture and dissipate heat.
Incontinence-associated dermatitis (IAD) frequently coexists with and is difficult to distinguish from pressure injury in the perineal/sacral region; both require different primary interventions (barrier protection and moisture control for IAD; offloading and repositioning for pressure injury) though they share risk factors and often occur together, complicating clinical staging. Structured incontinence care bundles include prompt cleansing with a pH-balanced, no-rinse cleanser after each episode, application of a skin barrier product (dimethicone- or petrolatum-based cream, or a cyanoacrylate barrier film) at every incontinence care episode, and use of highly absorbent, breathable containment products changed promptly rather than left saturated against skin.
Heel offloading deserves special mention: the heel has minimal subcutaneous tissue over the calcaneus and a watershed blood supply, making it second only to the sacrum in pressure injury incidence. Pillows alone are frequently displaced; purpose-built heel suspension boots/devices that float the heel completely off the mattress surface (achieving true zero interface pressure at the calcaneus while distributing lower leg weight along the calf) are the guideline-recommended standard for at-risk patients, rather than relying on pillow elevation alone.
Systematic, structured skin inspection at every position change or at minimum daily is the surveillance backbone of pressure injury prevention, enabling early detection of Stage 1 changes (non-blanchable erythema) before progression to full-thickness injury, and driving facility-level quality metrics.
The NPIAP (formerly NPUAP) staging system classifies pressure injury by depth and tissue involvement: Stage 1 — non-blanchable erythema of intact skin, may be painful, firm, soft, warmer or cooler than adjacent tissue (in darkly pigmented skin, may present as persistent blue/purple hue rather than classic redness, making visual inspection technique-dependent); Stage 2 — partial-thickness skin loss with exposed dermis, presenting as a shallow open ulcer or intact/ruptured serum-filled blister, without slough; Stage 3 — full-thickness skin loss with visible adipose tissue, granulation tissue and epibole (rolled wound edges) often present, may include undermining/tunneling; Stage 4 — full-thickness skin and tissue loss with exposed or directly palpable fascia, muscle, tendon, ligament, cartilage, or bone; Unstageable — full-thickness skin and tissue loss obscured by slough or eschar, true depth cannot be determined until adequately debrided; Deep Tissue Pressure Injury (DTPI) — persistent non-blanchable deep red, maroon, or purple discoloration, or blood-filled blister, indicating damage to underlying soft tissue that may evolve rapidly despite treatment.
Inspection at bony prominences — sacrum/coccyx, ischial tuberosities, greater trochanters, heels, occiput, ears (particularly with oxygen tubing or medical devices), and any area under a medical device — should occur at minimum daily for at-risk patients and at every repositioning episode for high/severe-risk patients, using consistent lighting and, in darkly pigmented skin, palpation for warmth, edema, and induration/tissue consistency change in addition to visual inspection, since erythema may not be visually apparent.
Facility-level surveillance tracks hospital-acquired pressure injury (HAPI) incidence, typically expressed per 1,000 patient-days, with benchmarks varying substantially by care setting — general acute wards often report well below 3%, while intensive care and long-term acute care populations, with higher device burden, hemodynamic instability, and immobility, report substantially higher rates in published surveillance data. Root-cause review of each HAPI event, documentation audits, and staff competency validation on Braden scoring and repositioning technique are standard components of a hospital pressure injury prevention program.